Novel Treatment Options in Head and Neck Cancer

被引：8
|
作者：
Schuler, Patrick J. [1 ]
Laban, Simon [1 ]
Doescher, Johannes [1 ]
Bullinger, Lars [2 ]
Hoffmann, Thomas K. [1 ]
机构：
[1] Ulm Univ, Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Frauensteige 12, D-89075 Ulm, Germany
[2] Ulm Univ, Med Ctr, Dept Internal Med 3, Ulm, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2017年 / 40卷 / 06期
关键词：
HNSCC; Immunotherapy; PD-1; Immune escape; Vaccination; SQUAMOUS-CELL CARCINOMA; OPEN-LABEL; RECURRENT; TRIAL; IMMUNOTHERAPY; MULTICENTER; COMBINATION; VACCINATION; MECHANISM; NIVOLUMAB;
D O I：
10.1159/000477254
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The treatment of head and neck squamous cell carcinoma (HNSCC) has been a medical challenge with limited improvement in overall survival over the past few decades. However, recently, very interesting innovations in the field of immunotherapy have been shown to be beneficial for patients with advanced HNSCC. In this article, the latest medical developments are reviewed with special focus on the clinical achievements and current clinical studies in the field of immunotherapy. The landscape of clinical studies has changed considerably from antibody-based growth factor inhibition towards immune checkpoint modulation, and new indications in the adjuvant and neoadjuvant setting are being tested in large patient cohorts. Even the combination of 2 or more immune modulatory approaches and the correct synchronization with standard cancer therapy is promising and warrants suitable clinical trials. (C) 2017 S. Karger GmbH, Freiburg
引用
收藏
页码：342 / 346
页数：5
相关论文
共 50 条
  • [1] Potentially novel options for treatment of HPV-attributable head and neck cancer
    Brakenhoff, Ruud H.
    CELL CYCLE, 2013, 12 (07) : 1020 - 1021
  • [2] Current Treatment Options for Metastatic Head and Neck Cancer
    Katharine A. R. Price
    Ezra E. Cohen
    Current Treatment Options in Oncology, 2012, 13 : 35 - 46
  • [3] Current Treatment Options for Metastatic Head and Neck Cancer
    Price, Katharine A. R.
    Cohen, Ezra E.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2012, 13 (01) : 35 - 46
  • [4] Influence of treatment volume on fractionation options in head and neck cancer radiotherapy
    Harari, PM
    VOLUME & KINETICS IN TUMOR CONTROL & NORMAL TISSUE COMPLICATIONS, 1998, : 288 - 288
  • [5] The SPECTRUM of findings in treatment options for recurrent/metastatic head and neck cancer
    Misiukiewicz, Krzysztof
    Posner, Marshall
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2013, 2 (06) : 533 - 535
  • [6] In vitro models as tools for screening treatment options of head and neck cancer
    Seliger, Barbara
    Al-Samadi, Ahmed
    Yang, Bo
    Salo, Tuula
    Wickenhauser, Claudia
    FRONTIERS IN MEDICINE, 2022, 9
  • [7] Reconstruction Options of Cancer of Head and Neck Region
    Bin Fokhrul, A. Talha
    Munira, S.
    BRITISH JOURNAL OF SURGERY, 2018, 105 : 147 - 147
  • [8] Optimizing approaches to head and neck cancer. Metastatic head and neck cancer: new options
    Licitra, L.
    Locati, L. D.
    Bossi, P.
    ANNALS OF ONCOLOGY, 2008, 19 : 200 - 203
  • [9] Cetuximab in the management of locoregionally advanced head and neck cancer: Expanding the treatment options?
    Bourhis, Jean
    Lefebvre, Jean-Louis
    Vermorken, Jan B.
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (11) : 1979 - 1989
  • [10] Novel agents and incremental advances in the treatment of head and neck cancer
    Khuri, FR
    Jain, SR
    SEMINARS IN ONCOLOGY, 2004, 31 (02) : 3 - 10
12345